Get your Thyroid Ablation Iodine-131 Therapy (30 mCi) treatment from a diagnostic centre specialised in Nuclear Medicine (NABL & NABH Accredited), Molecular Diagnostics and Therapy. Radioactive iodine treatment can be offered as an option for the destruction of thyroid tissue remaining after an operation, in selected patients with differentiated thyroid cancer, to meet clinical needs and by specialist opinion.

About Iodine-131 Therapy – 30 mCi for Thyroid Ablation

Targeted radionuclide treatment for a very specific target is the therapy of thyroid tissue left after surgery is made up of targeted iodine-131 therapy. In special patients, it is recommended generally following the thyroid surgery, based on the diagnosis and treatment. The iodine will go into cells of the thyroid, and the radiation will be absorbed by the tissue being targeted. This can be helpful to remove all the thyroid tissue and assist in subsequent thyroid cancer monitoring, if clinically indicated.

What is Iodine-131 Thyroid Ablation?

Treatment involves taking radioactive iodine (usually as a liquid or capsule) by mouth (also known as ablation of the thyroid using the radioactive form of iodine (I-131)). Iodine-131 is absorbed by thyroid cells, and then emits radiation that destroys the target tissue in the thyroid. Thyroid radio-ablation may be suggested following surgery to remove any remaining thyroid tissue in those who have a diagnosis of differentiated thyroid cancer. The choice of the 30 mCi activity is dependent on the diagnosis, risk assessment, the surgical features, and the opinion of the treating Nuclear Medicine specialist.

Common Reasons for Iodine-131 Therapy – 30 mCi

• Used after thyroids are removed: Post-Thyroidectomy Ablation: Can be used to remove any remaining thyroid after surgery.
• Surgery for differentiated thyroid cancer: May be recommended during the surgical evaluation for some people with papillary or follicular thyroid cancer.
• Post-Surgical Treatment Planning: May be part of the treatment plan after surgery, in some cases of thyroid cancer.
• Follow-Up Monitoring: If appropriate, removal of additional thyroid tissue may allow for simpler follow-up monitoring based upon thyroglobulin level.
• Individualized Treatment: Activity prescribed is dependent on the characteristics of the disease, treatment objectives, and risk category.

Conditions Evaluated and Treated

Residual Thyroid Tissue

Following a thyroid removal, a hint of thyroid tissue can stay. Following a thyroid surgical procedure, some very little thyroid tissue can remain. Remnant ablation can be recommended for people who have iodine-131 therapy, which can help destroy this tissue.

Papillary Thyroid Carcinoma

In some individuals who have papillary thyroid cancer, radioactive iodine could also be used after the surgery to destroy any small amounts of thyroid tissue present.

Differentiated Thyroid Cancer

Radioactive iodine (ablation) can be used to treat the few cells of differentiated (thyroid) cancer that are left in or after surgery in some people.

Why Choose Molecular Diagnostics and Therapy?

Molecular Diagnostics and Therapy has specialized amenities for Nuclear Medicine, Radiology, & Pathology services and is an NABL & NABH-accredited pathology centre. We continuously advise experts, have proper treatment procedures and radiation safety measures, as well as patient-centred care for our Nuclear Medicine services. They explain to patients how they are treated and what to do after treatment.

Book Your Iodine-131 Therapy – 30 mCi for Thyroid Ablation.

If you are considering thyroid ablation (30 mCi), there's additional information and suggestions for treatment available in Molecular Diagnostics and Therapy. Bring to the specialist: medical records and information about surgical procedures, information from the histopathology report, blood tests, previous imaging reports (MRIs, PETs), and previous treatment (if done with radioactive iodine). The treatment provider will confirm treatment eligibility and the activity the person is to do.